First Manhattan
YTEN

First Manhattan’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

First Manhattan’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-14
Closed -$2K – 1428
2020
Q3 		$2K Buy
+14
New +$2.07K ﹤0.01% 1277

Other funds holding YTEN

CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
HDIM
Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

First Manhattan's YTEN Position: Q4 2020 in Review

First Manhattan sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q4 2020, closing a stake of 14 shares — an estimated $2K sold.

First Manhattan first reported a position in YTEN in Q3 2020 and held it in 1 quarter. The position peaked at $2K in Q3 2020. 8 funds tracked by Wall St. Rank hold YTEN as of Q4 2020.

  • First Manhattan reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • First Manhattan sold 14 Yield10 Bioscience, Inc. Common Stock shares in Q4 2020, an estimated $2K.
  • First Manhattan first reported a position in Yield10 Bioscience, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • First Manhattan's Yield10 Bioscience, Inc. Common Stock position peaked at $2K in Q3 2020.
  • 8 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q4 2020.

Based on First Manhattan's 13F filing for Q4 2020, filed 16 Feb 2021.